Volume 15 Supplement 4

Selected articles on Computational Vaccinology 2013

Research

Edited by Anne De Groot, Yongqun He and Phoebe De Groot

Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. Articles have undergone the journal's standard review process for supplements. Anne De Groot declares that she is the founder and majority shareholder at EpiVax Inc., a privately owned vaccine design company located in Providence, Rhode Island, USA which developed and owns the right to the iVAX platform. The Supplement Editors declare that there is a potential conflict of interest related to Dr De Groot's relationship with EpiVax and attest that the work contained in this supplement is free of any bias that might be associated with the commerical goals of the company. The other Supplement Editors declare that they have no competing interests.

The 3rd ISV Pre-conference Computational Vaccinology Workshop (ICoVax 2013). Go to conference site.

Barcelona, Spain26 October 2013